Quantitative reverse-transcription polymerase chain reaction analysis of alzheimer's-associated genes in mouse scrapie

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 17-18, 2009, Pages 1075-1082

  Medina, Sarah ^a   Hatherall, Avril ^a,b   Parchaliuk, Debra ^a   Robertson, Catherine ^a   Booth, Stephanie A ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; EXCITOTOXICITY; GENE EXPRESSION REGULATION; GENE FUNCTION; INFLAMMATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCRAPIE; UPREGULATION; ANIMAL; BRAIN; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

MUS;

ANIMALS; BRAIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCRAPIE;

EID: 69849086875     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903084561     Document Type: Article

References (28)

1. Agostinho, P., Lopes, J. P., Velez, Z., and Oliveira, C. R. 2008. Overactivation of calcineurin induced by amyloid-beta and prion proteins. Neurochem. Int. doi:10.1016/j.neuint. 2008.01.005.
2. Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and Landfield, P. W. 2004. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 101:2173-2178.
3. Booth, S., Bowman, C., Baumgartner, R., Sorensen, G., Robertson, C., Coulthart, M., Phillipson, C., and Somorjai, R. L. 2004. Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 85:3459-3471.
4. Cortijo-Arellano, M., Ponce, J., Durany, N., and Cladera, J. 2008. Amyloidgenic properties of the prion protein fragment PrP(185-208): Comparison with Alzheimer's peptide Aß(1 -28), influence of heparin and cell toxicity. Biochem. Biophys. Res. Commun. 368:238-242.
5. Counts, S. E., Perez, S. E., Ginsberg, S. D., De Lacalle, S., and Mufson, E. J. 2003. Galanin in Alzheimer disease. Mol. Interv. 3:137-156.
6. Crozet, C., Vézilier, J., Delfieu, V., Nishimura, T., Onodera, T., and Casanova, D. 2006. The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic, Mol. Cell. Neurosci. 32:315-323.
7. Ding, X., MacTavish, D., Kar, S., and Jhamandas, J. H. 2006. Galanin attenuates beta amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol. Dis. 21:413-420.
8. Harrison, R. S., Sharpe, P. C., Singh, Y., and Fairlie, D. P. 2007. Amyloid peptides and proteins in review. Rev. Physiol. Biochem. Pharmacol. 159:1-77.
9. Hun Lim, K., Collver, H. H., Le, Y. T. H., Nagchowdhuri, P., and Kenny, J. M. 2007.Characteristics of distinct amyloidogenic conformations of the Aß(1-40) and (1-42) peptides. Biochem. Biophys. Res. Commun. 353:443-449.
10. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., DeLucia, M., Lin, W. L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., and Golde, T. 2005. Aß42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47:191-199.
11. Mirnics, K., Korade, Z., Arion, D., Lazarov, O., Unger, T., Macioce, M., Sabatini, M., Terrano, D., Douglass, K. C., Schor, N. F., and Sisodia, S. S. 2005. Presenilin-1-dependent transcriptome changes. J Neurosci. 25:1571-1578.
12. Oddo, S. Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., and LaFerla, F. M. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Aß and synaptic dysfunction.Neuron 39:409-421.
13. Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., and Domenici, L. 2008. Receptor for advanced glycation end product -dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta -mediated cortical synaptic dysfunction. J. Neurosci. 28:3521-3530.
14. Parkin, E. T., Watt, N. T., Hussain, I., Echman, E. A., Eckman, C. B., Manson, J. C., Baybutt, H. N., Turner, A. J., and Hooper, N. M. 2007. Cellular prion protein regulates ß-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc.Natl. Acad. Sci. USA 104:11062-11067.
15. Prusiner, S. B. 2001. Neurodegenerative diseases and prions. N. Engl. J. Med. 344:1516-1526.
16. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
17. Reddy, P.H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R., Mori, M., and Quinn, J. 2004. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13:1225-1240.
18. Reimer, C., Neidhold, S., Burwinkel, M., Schwarz, A., Schultz, J., Kratzschmar, J., Monning, U., and Baier, M. 2004. Gene expression profiling of scrapieinfected brain tissue. Biochem. Biophys. Res. Commun. 323:556-564.
19. Sasaki, N., Takeuchi, M., Chowei, H., Kikuchi, S., Hayashi, Y., Nakano, N., Ikeda, H., Yamagishi, S., Kitamoto, T., Saito, T., and Makita, Z. 2002. Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. Neurosci. Lett. 326:117-120.
20. Sisó, S., Puig, B., Varea, R., Vidal, E., Acín, C., Prinz, M., Montrasio, F., Badiola, J., Aguzzi, A., Pumarola, M., and Ferrer, I. 2002. Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. 103:615-626.
21. Sorensen, G., Medina, S., Parchaliuk, D., Phillipson, C., Robertson, C., and Booth, S. A. 2008. Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes. BMC Genom. 3(9):114.
22. Stockley, J. H., Ravid, R., O'Neill, C. 2006. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain. FEBS Left. 580:6550-6560.
23. Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., and Barnham, K. J. 2008. Stabilization of neurotoxic soluble ßsheet-rich conformations of the Alzheimer's disease amyloid-ß peptide. Biophys. J. 94:2752-2766.
24. Vincent, B., Cisse, M. A., Sunyach, C., Guillot-Sestier, M. V., and Checler, F. 2008. Regulation of betaAPP and PrPc cleavage by alphasecretase: Mechanistic and therapeutic perspectives. Curr. Alzheimer Res. 5:202-211.
25. Vincent, I., Jicha, G., Rosado, M., and Dickson, D. W. 1997. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17:3588-3598
26. Winklhofer, K., Tatzelt, J., and Haass, C. 2008. The two faces of protein misfolding:Gain- and loss-of-function in neurodegenerative diseases. EMBO J. 27:336-349.
27. Wisniewski, T., and Sigurdsson, M. 2007. Therapeutic approaches for prion Alzheimer's diseases. FEBS J. 274:3784-3798.
28. Xiang, W., Windl, O., Wunsch, G., Dugas, M., Kohlmann, A., Dierkes, N., Westner, I. M., and Kretzschmar, H. A. 2004. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression echnology. J. Virol. 78:11051-11060.